Literature DB >> 17158386

Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure?

R J Heine1, M Diamant, J-C Mbanya, D M Nathan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17158386      PMCID： PMC1693603          DOI： 10.1136/bmj.39022.462546.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  25 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

Review 2.  Thiazolidinediones.

Authors:  Hannele Yki-Järvinen
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

3.  Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide.

Authors:  A Holstein; A Plaschke; E H Egberts
Journal:  Diabetes Metab Res Rev       Date:  2001 Nov-Dec       Impact factor: 4.876

Review 4.  Biologic actions and therapeutic potential of the proglucagon-derived peptides.

Authors:  Daniel J Drucker
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2005-11

Review 5.  Sulfonylureas in NIDDM.

Authors:  L C Groop
Journal:  Diabetes Care       Date:  1992-06       Impact factor: 19.112

Review 6.  Dietary advice for treatment of type 2 diabetes mellitus in adults.

Authors:  H Moore; C Summerbell; L Hooper; K Cruickshank; A Vyas; P Johnstone; V Ashton; P Kopelman
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.

Authors:  Giancarlo Viberti; Steven E Kahn; Douglas A Greene; William H Herman; Bernard Zinman; Rury R Holman; Steven M Haffner; Daniel Levy; John M Lachin; Rhona A Berry; Mark A Heise; Nigel P Jones; Martin I Freed
Journal:  Diabetes Care       Date:  2002-10       Impact factor: 19.112

8.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

Authors:  R A DeFronzo; A M Goodman
Journal:  N Engl J Med       Date:  1995-08-31       Impact factor: 91.245
View more
  17 in total

1.  Observations and recommendations for community-based diabetes screenings.

Authors:  Brian West; Punam Parikh; Guedy Arniella; Carol R Horowitz
Journal:  Diabetes Educ       Date:  2010-11-01       Impact factor: 2.140

2.  Type 2 diabetes mellitus in patients with mild obesity: preliminary results of surgical treatment.

Authors:  Enrique Lanzarini; Attila Csendes; Luis Gutierrez; Pedro Cuevas; Hanns Lembach; Juan C Molina; Maher Musleh; Italo Braghetto; Karin Papapietro; Verónica Araya; Rodolfo Lahsen; Pablo Olguin; Andrea Riffo; Emma Diaz; Denisse Montt; Luciana Marín
Journal:  Obes Surg       Date:  2013-02       Impact factor: 4.129

Review 3.  Emerging treatment options for type 2 diabetes.

Authors:  Milan K Piya; Abd A Tahrani; Anthony H Barnett
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

4.  Gongronema latifolium delays gastric emptying of semi-solid meals in diabetic dogs.

Authors:  Sylvester Osita Ogbu; Kenneth Kalu Agwu; Isaac Uzoma Asuzu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-08-12

5.  Risk factors for type 2 diabetes mellitus preceded by β-cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study.

Authors:  Fumiaki Imamura; Kenneth J Mukamal; James B Meigs; José A Luchsinger; Joachim H Ix; David S Siscovick; Dariush Mozaffarian
Journal:  Am J Epidemiol       Date:  2013-05-24       Impact factor: 4.897

6.  Patients' perceptions and experiences of transitions in diabetes care: a longitudinal qualitative study.

Authors:  Julia Lawton; David Rankin; Elizabeth Peel; Margaret Douglas
Journal:  Health Expect       Date:  2009-03-20       Impact factor: 3.377

7.  Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes.

Authors:  Mathijs C Bunck; Anja Cornér; Bjorn Eliasson; Robert J Heine; Rimma M Shaginian; Marja-Riitta Taskinen; Ulf Smith; Hannele Yki-Järvinen; Michaela Diamant
Journal:  Diabetes Care       Date:  2011-09       Impact factor: 19.112

Review 8.  Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues.

Authors:  Allan Vaag; Søren S Lund; Sørens Lund
Journal:  Eur J Endocrinol       Date:  2011-09-19       Impact factor: 6.664

9.  Methods and models for metabolic assessment in mice.

Authors:  G Pacini; B Omar; B Ahrén
Journal:  J Diabetes Res       Date:  2013-05-21       Impact factor: 4.011

10.  Interaction of herbal compounds with biological targets: a case study with berberine.

Authors:  Xiao-Wu Chen; Yuan Ming Di; Jian Zhang; Zhi-Wei Zhou; Chun Guang Li; Shu-Feng Zhou
Journal:  ScientificWorldJournal       Date:  2012-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.